Bluejay Diagnostics Inc. (BJDX)
3.97
0.04 (1.02%)
At close: Jan 28, 2025, 2:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -9.95M | -9.30M | -3.49M | -1.16M | -819.84K |
| Depreciation & Amortization | 780.96K | 306.37K | 145.72K | 157.04K | 142.97K |
| Stock-Based Compensation | 189.25K | 433.00K | 68.46K | 7.37K | 14.81K |
| Other Working Capital | 902.49K | 279.66K | -1.49M | 211.07K | -48.55K |
| Other Non-Cash Items | 3.09K | 237.45K | 222.01K | -153.53K | -839.94K |
| Deferred Income Tax | n/a | n/a | 170.66K | 42.43K | -9.84K |
| Change in Working Capital | 666.73K | 578.54K | -1.49M | 596.26K | -178.28K |
| Operating Cash Flow | -8.31M | -7.74M | -4.37M | -508.71K | -1.69M |
| Capital Expenditures | -704.17K | -1.20M | -23.95K | n/a | -6.02K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -704.17K | -1.20M | -23.95K | n/a | -6.02K |
| Debt Repayment | -4.81K | -801 | 4.20M | 270.00K | -265.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | -17.67K | n/a | n/a |
| Other Financial Acitivies | 956.53K | 8.88K | -513.47K | 1.06M | 1.78M |
| Financial Cash Flow | 1.11M | 8.07K | 22.53M | 1.33M | 1.51M |
| Net Cash Flow | -7.91M | -8.93M | 18.14M | 816.35K | -184.34K |
| Free Cash Flow | -9.02M | -8.94M | -4.39M | -508.71K | -1.70M |